Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Fenamate NSAIDs inhibit the NLRP3 inflammasome and 2 protect against Alzheimer’s disease in rodent models, published in the journal Nature Communications. DOI: 10.1038/NCOMMS12504 Please note, this ...

These treatments are only effective for people with Alzheimer’s disease, dementia with Lewy bodies ... Standard tablets and capsules release the medication into the body as soon as they are swallowed.

Hints that the removal of amyloid plaques — which are a defining feature of Alzheimer's disease — may not be essential for improving cognition, could have implications for future treatments.

Alzheimer's leans to memory loss then progressive failure of mental and physical functions Early results in a new treatment for one of the most common forms of dementia have been "absolutely ...

Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium.

This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...

(“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease ...

China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen's Leqembi received approval in January ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment of Early Alzheimer’s Disease: Results from the ...